Power Law company profile

Intarcia Therapeutics

Biotech & Life Sciences · Boston, United States · Founded 1997 Unicorn

Develops innovative therapies aimed at Diabetes

Valuation

$2.5–5B

Latest valuation · 2026

Unlock exact value

Headcount

<100

Current team size

Unlock exact value

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

10 investors on Intarcia Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 10 investors entered at this stage

Marker LLC

Farallon Capital Management

Bill & Melinda Gates Foundation

InterWest Partners

RA Capital Management

Alta Partners

Global footprint

Where Intarcia Therapeutics has talent and traffic

Workforce by country

4 countries with
team presence

🇺🇸 United States93.5%

🇵🇰 Pakistan2.2%

🇮🇪 Ireland2.2%

🇮🇳 India2.2%

4 countries shown

Web traffic by country

930 monthly visits
across markets

🇺🇸 United States96.8%

Top 1 markets shown

Patent intelligence

$49M patent portfolio · 22 active families

Estimated portfolio value

$49M

1.3% of valuation · 10.3× smaller than top peer Insulet ($502M)

22 active patent families

Where Intarcia Therapeutics innovates Biomedical engineeringDelivery systemPeptideDrug deliveryMolecular biology

Where Intarcia Therapeutics concentrates vs peers

Each axis is a top-10 topic across Intarcia Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Intarcia Therapeutics

An AI-synthesized read of the highest-engagement posts about Intarcia Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Intarcia Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles